Literature DB >> 10575583

Relationship between the sperm motility index assessed by the sperm quality analyzer and the outcome of intracytoplasmic sperm injection.

H Shibahara1, Y Hamada, A Hasegawa, E Wakimoto, H Toji, M Shigeta, K Koyama.   

Abstract

PURPOSE: Intracytoplasmic sperm injection (ICSI) has been validated as a useful treatment in severe male-factor patients who could not achieve fertilization and live births by conventional in vitro fertilization treatment. To examine the impact of male factors on ICSI outcome, clinical laboratory data were retrospectively analyzed.
METHODS: One hundred two cycles of ICSI treatment indicated by severe male-factor infertility were entered into this study. Sperm parameters including sperm motility, sperm concentration, and sperm motility index assessed by the Sperm Quality Analyzer were evaluated.
RESULTS: Five hundred seventy-six metaphase II oocytes retrieved were manipulated. The normal fertilization (2 PN) rate per oocyte was 64.9 +/- 26.0% (mean +/- SD). Of the 99 transfers, 31 clinical pregnancies were obtained, yielding an average pregnancy rate of 31.3% per transfer. The mean sperm motility, sperm concentration, and sperm motility index were 20.3 +/- 16.1% (range, 0 to 50%), 18.2 +/- 25.1 x 10(6)/ml (range, < 1 to 150 x 10(6)/ml), and 31.2 +/- 45.0 (range, 0 to 220), respectively. Sperm concentration did not have a significant impact on fertilization rate by ICSI. In four cases, ICSI was performed using totally immotile sperm and the fertilization rate was 43.5%, which was significantly lower than that of some of the other sperm motility groups, and no pregnancy could be achieved. In 14 cases in which the sperm motility index assessed by the Sperm Quality Analyzer was 0, the fertilization rate (50.0%) was significantly lower than in most of the other sperm motility index groups.
CONCLUSIONS: These findings suggest that in severe male-factor cases with totally immotile sperm or a sperm motility index of 0, the selection of good-quality sperm should be verified before injection.

Entities:  

Mesh:

Year:  1999        PMID: 10575583      PMCID: PMC3455380          DOI: 10.1023/a:1020501305235

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  30 in total

1.  The outcome of intracytoplasmic sperm injection is unrelated to 'strict criteria' sperm morphology.

Authors:  P Svalander; A H Jakobsson; A S Forsberg; A C Bengtsson; M Wikland
Journal:  Hum Reprod       Date:  1996-05       Impact factor: 6.918

2.  A case of primary ovarian pregnancy after in vitro fertilization and embryo transfer.

Authors:  H Shibahara; M Funabiki; T Shiotani; Y Ikeda; K Koyama
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

3.  Obstetric outcome of 904 pregnancies after intracytoplasmic sperm injection.

Authors:  A Wisanto; M Bonduelle; M Camus; H Tournaye; M Magnus; I Liebaers; A Van Steirteghem; P Devroey
Journal:  Hum Reprod       Date:  1996-12       Impact factor: 6.918

4.  Pregnancy and birth after intracytoplasmic sperm injection with totally immotile sperm recovered from the ejaculate.

Authors:  A Barros; M Sousa; C Oliveira; J Silva; V Almeida; J Beires
Journal:  Fertil Steril       Date:  1997-06       Impact factor: 7.329

5.  Prospective follow-up study of 877 children born after intracytoplasmic sperm injection (ICSI), with ejaculated epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI.

Authors:  M Bonduelle; A Wilikens; A Buysse; E Van Assche; A Wisanto; P Devroey; A C Van Steirteghem; I Liebaers
Journal:  Hum Reprod       Date:  1996-12       Impact factor: 6.918

6.  Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles.

Authors:  J Liu; Z Nagy; H Joris; H Tournaye; J Smitz; M Camus; P Devroey; A Van Steirteghem
Journal:  Hum Reprod       Date:  1995-10       Impact factor: 6.918

7.  Effects of sperm immobilizing antibodies on pregnancy outcome in infertile women treated with IVF-ET.

Authors:  H Shibahara; M Mitsuo; Y Ikeda; M Shigeta; K Koyama
Journal:  Am J Reprod Immunol       Date:  1996-08       Impact factor: 3.886

8.  Pregnancies achieved with testicular and ejaculated spermatozoa in combination with intracytoplasmic sperm injection in men with totally or initially immotile spermatozoa in the ejaculate.

Authors:  S Kahraman; M Tasdemir; I Tasdemir; K Vicdan; S Ozgur; G Polat; A Z Islk; K Biberoğlu; P Vanderzwalmen; M Nijs; R Schoysman
Journal:  Hum Reprod       Date:  1996-06       Impact factor: 6.918

9.  Fertilizing ability of immotile spermatozoa after intracytoplasmic sperm injection.

Authors:  M Nijs; P Vanderzwalmen; B Vandamme; G Segal-Bertin; B Lejeune; L Segal; E van Roosendaal; R Schoysman
Journal:  Hum Reprod       Date:  1996-10       Impact factor: 6.918

10.  The hypo-osmotic swelling test for selection of viable sperm for intracytoplasmic sperm injection in men with complete asthenozoospermia.

Authors:  R F Casper; J S Meriano; K A Jarvi; L Cowan; M L Lucato
Journal:  Fertil Steril       Date:  1996-05       Impact factor: 7.329

View more
  3 in total

1.  Relationships between sperm motility characteristics assessed by the computer-aided sperm analysis (CASA) and fertilization rates in vitro.

Authors:  Y Hirano; H Shibahara; H Obara; T Suzuki; S Takamizawa; C Yamaguchi; H Tsunoda; I Sato
Journal:  J Assist Reprod Genet       Date:  2001-04       Impact factor: 3.412

2.  Performing ICSI using an injection pipette with the smallest possible inner diameter and a long taper increases normal fertilization rate, decreases incidence of degeneration and tripronuclear zygotes, and enhances embryo development.

Authors:  Y Yavas; S Roberge; F Khamsi; P Shirazi; M W Endman; J C Wong
Journal:  J Assist Reprod Genet       Date:  2001-08       Impact factor: 3.412

Review 3.  Management of primary ciliary dyskinesia/Kartagener's syndrome in infertile male patients and current progress in defining the underlying genetic mechanism.

Authors:  Yan-Wei Sha; Lu Ding; Ping Li
Journal:  Asian J Androl       Date:  2014 Jan-Feb       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.